7-Jun-2018
Noxopharm Corporate Presentation for Public Briefing Noxopharm Corporate Presentation for Public Briefing

7-May-2018
Noxopharm CEO Interview Updates the Company's Current Research and Development Program Noxopharm CEO Interview Updates the Company's Current Research and Development Program

3-May-2018
Noxopharm CEO Interview on near-completed NOX66 chemotherapy trial CEP-1 Noxopharm CEO Interview on near-completed NOX66 chemotherapy trial CEP-1

27-Apr-2018
Noxopharm CEO Interview with FNN on the Company's NOX66 and Radiotherapy Clinical Programs Noxopharm CEO Interview with FNN on the Company's NOX66 and Radiotherapy Clinical Programs

21-Mar-2018
TROG Annual Scientific Meeting - Noxopharm Presentation 21.3.18 TROG Annual Scientific Meeting - Noxopharm Presentation 21.3.18

12-Mar-2018
Corporate Presentation - Post Interim Clinical Data Release Corporate Presentation - Post Interim Clinical Data Release

6-Mar-2018
Noxopharm CEO talks to FNN about CEP-1 Clinical Study Interim Data from 2018 TAT Congress in Paris, March 5-7 Noxopharm CEO talks to FNN about CEP-1 Clinical Study Interim Data from 2018 TAT Congress in Paris, March 5-7

6-Dec-2017
NOX Open Briefing Corporate Presentation NOX Open Briefing Corporate Presentation

29-Nov-2017
Noxopharm Limited 2017 AGM Webcast, November 27, 2017 Noxopharm Limited 2017 AGM Webcast, November 27, 2017

27-Nov-2017
AGM Presentations AGM Presentations